Cite
HARVARD Citation
McCrimmon, R. et al. (2023). IGlarLixi versus basal plus Rapid‐Acting insulin in adults with type 2 diabetes advancing from basal insulin therapy: The SoliSimplify Real‐World study. Diabetes, obesity & metabolism. 25 (1), pp. 68-77. [Online].